MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-19-0032390
Mediverve Laboratories Private Limited
Mediverve Laboratories Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹1.46 Cr
▲ 11% YoY
Net profit · FY 2024
₹2.96 Lakh
Net margin 2%
EBITDA · FY 2024
₹9.3 Lakh
EBITDA margin 6.4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹88 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Employees · EPFO
21
Provident fund records
About Mediverve Laboratories Private Limited
Data last updated:
Mediverve Laboratories Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH2020PTC352733. Its GSTIN is 27AAOCM1742N1ZY (Maharashtra). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Raj Ranjan Kumar and Kumari Rashmi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No 112 Plot No 9 Sector 15 CBD Belapur Navi Mumbai, Maharashtra, India – 400614.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.46 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹2.96 Lakh (net margin 2%) and EBITDA of ₹9.3 Lakh (EBITDA margin 6.4%).
The company has about 21 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹88 Lakh on record.
Mediverve Laboratories Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0032390).
Company details
CIN U24110MH2020PTC352733
Registration Number 352733
Incorporation Date 30 December 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0032390
Recognitions & Rankings of Mediverve Laboratories
Contact details
Mediverve Laboratories Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No 112 Plot No 9 Sector 15 CBD Belapur Navi Mumbai, Maharashtra, India – 400614
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Mediverve Laboratories Private Limited, buy the company report.
Comprehensive company report
Mediverve Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Mediverve Laboratories is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Mediverve Laboratories Private Limited, buy the company report.
Financials of Mediverve Laboratories Private Limited
FY 2025 filings availableMediverve Laboratories Private Limited reported revenue of ₹1.46 Cr (up 11% YoY) for FY 2024.
Revenue · FY 2024
₹1.46 Cr ▲ 11%
Net profit · FY 2024
₹2.96 Lakh margin 2%
EBITDA · FY 2024
₹9.3 Lakh margin 6.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 11%
EBITDA CAGR growth
1 year
▲ 79%
3 years · compounded
▲ 58%
Revenue rose 11% in the latest year. EBITDA rose 79% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹9.3 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹2.96 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 6.4% | |||
| Net Profit Margin | 2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Mediverve Laboratories Private Limited, buy the company report.
Board of directors of Mediverve Laboratories Private Limited
Mediverve Laboratories has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raj Ranjan Kumar | Director | 30 Dec 2020 | 5 Years 10 Months | Current |
| Kumari Rashmi | Director | 30 Dec 2020 | 5 Years 10 Months | Current |
| Subhangi Kumari | Additional Director | 03 Sep 2025 | 1 Years 1 Months | Current |
Peer comparison
Mediverve Laboratories Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (human health activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Chitra Multi-Speciality Hospitals Private Limited | ₹1.47 Cr (FY 2024) | 7.0% | Rajapalayam, Tamil Nadu, India | |||
| Lifetrust Healthcare Private Limited | ₹1.46 Cr (FY 2025) | -40.0% | Talwandi Sabo, Punjab, India | |||
| Jaswik Healthcare Private Limited | ₹1.46 Cr (FY 2025) | 352.0% | Jalgaon, Maharashtra, India | |||
| Gethe's Hospital Private Limited | ₹1.46 Cr (FY 2025) | 5.0% | Pune, Maharashtra, India | |||
| Lalita Memorial Hospital Private Limited | ₹1.46 Cr (FY 2024) | -8.0% | New Delhi, Delhi, India | |||
| Mediverve Laboratories Private Limitedthis company | ₹1.46 Cr (FY 2024) | ₹2.96 Lakh | 2% | 11.0% | 21 | Mumbai, Maharashtra, India |
| Sanjeevanijammikunta Health Care Private Limited | ₹1.46 Cr (FY 2025) | 63.0% | Karimnagar, Telangana, India | |||
| Anvika Hospital Private Limited | ₹1.46 Cr (FY 2025) | 15.0% | Wardha, Maharashtra, India | |||
| Remedium Pharma Private Limited | ₹1.45 Cr (FY 2025) | 30.0% | Pune, Maharashtra, India | |||
| Vashisht Clinic Private Limited | ₹1.45 Cr (FY 2024) | -43.0% | New Delhi, Delhi, India | |||
| Modern Health Care Private Limited | ₹1.45 Cr (FY 2025) | 83.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Mediverve Laboratories Private Limited, buy the company report.
Auditor
Mediverve Laboratories Private Limited is audited by Ganesh Hadvale & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Ganesh Hadvale & Associates | FY 2023 | 133709 |
Shareholding
The shareholding of Mediverve Laboratories Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Mediverve Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
₹88 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Nov 2024 | 101035104 | Others | ₹88 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Mediverve Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Mediverve Laboratories Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2022, listing 3 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Shree Printstop |
To see the full MSME payment records of Mediverve Laboratories Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Mediverve Laboratories Private Limited has a workforce of 21 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.
Employee count
21
Active EPFO establishments
1
Employee growth
-4.55%
GST
Mediverve Laboratories has 3 GST registrations: 3 active.
Total GSTINs
3
Active
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAOCM1742N1ZY | Maharashtra | Active | 20 Jan 2021 |
| 20AAOCM1742N1ZC | Jharkhand | Active | 27 Apr 2021 |
| 10AAOCM1742N1ZD | Bihar | Active | 20 Jul 2023 |
To see the full GST registrations and return filing status of Mediverve Laboratories Private Limited, buy the company report.
Recent activity
Mediverve Laboratories Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Subhangi Kumari was appointed as Additional Director on 03 Sep 2025.
AGM
Mediverve Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Subhangi Kumari was appointed as Additional Director.
Filing
Mediverve Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
A charge with Others amounted to Rs. 88.00 Lakh with Charge ID 101035104 was registered on 19 Nov 2024.
Appointed
Kumari Rashmi was appointed as Director.
Appointed
Raj Ranjan Kumar was appointed as Director.
Incorporation
30 Dec 2020
Mediverve Laboratories Private Limited was registered on 30 Dec 2020 with Roc Mumbai I & aged 5 years 10 months as per MCA records.
Frequently asked questions
Mediverve Laboratories is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 December 2020 (6+ years old) and is registered under CIN U24110MH2020PTC352733.
Mediverve Laboratories has 3 current directors:
- Raj Ranjan Kumar - Director
- Kumari Rashmi - Director
- Subhangi Kumari - Additional Director
The latest financial statements of Mediverve Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Mediverve Laboratories is 27AAOCM1742N1ZY, registered in Maharashtra. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 20AAOCM1742N1ZC (Jharkhand), 10AAOCM1742N1ZD (Bihar).
The CIN (Corporate Identification Number) of Mediverve Laboratories is U24110MH2020PTC352733. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mediverve Laboratories was incorporated on 30 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Mediverve Laboratories by revenue are Chitra Multi-Speciality Hospitals Private Limited, Lifetrust Healthcare Private Limited, Jaswik Healthcare Private Limited, Gethe's Hospital Private Limited, Lalita Memorial Hospital Private Limited and 5 more, all in the same principal business activity (human health activities).
Subhangi Kumari was appointed as Additional Director on 03 Sep 2025. Kumari Rashmi was appointed as Director on 30 Dec 2020. Raj Ranjan Kumar was appointed as Director on 30 Dec 2020.
Yes, Mediverve Laboratories is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0032390).
Mediverve Laboratories has 1 MSME Form 1 return on record for the period ending Mar 2022, listing 3 overdue payments to 1 micro and small supplier. The latest return was filed on 30 Apr 2022.
The registered office of Mediverve Laboratories is at Shop No 112 Plot No 9 Sector 15 CBD Belapur Navi Mumbai, Maharashtra, India – 400614.
Mediverve Laboratories operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages